To chromo or not to chromo: That is the question

References (1)

1. Gaidos JK, Bickston SJ. How to Optimize Colon Cancer Surveil- lance in Inflammatory Bowel Disease Patients. Inflamm Bowel Dis 2016; 22: 1219-30. [CrossRef] Awais D, Siegel CA, Higgins PD. Modelling dysplasia detection in ulcerative colitis: clinical implications of surveillance intensity. Gut 2009; 58: 1498-503. [CrossRef] Mooiweer E, van der Meulen-de Jong AE, Ponsioen CY, et al. Chromoendoscopy for Surveillance in Inflammatory Bowel Dis- ease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study. Am J Gastroenterol 2015; 110: 1014- 21. [CrossRef] Eaden JA, Ward BA, Mayberry JF. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000; 51: 123-8. [CrossRef] Rutter MD, Saunders BP, Wilkinson KH, Kamm MA, Williams CB, Forbes A. Most dysplasia in ulcerative colitis is visible at colonos- copy. Gastrointest Endosc 2004; 60: 334-9. [CrossRef] Mowat C, Cole A, Windsor A, et al. Guidelines for the manage- ment of inflammatory bowel disease in adults. Gut 2011; 60: 571- 607. [CrossRef] Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013; 7: 1-33. [CrossRef] Laine L, Kaltenbach T, Barkun A, et al. SCENIC international con- sensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015; 148: 639- 51.e28. [CrossRef] Gasia MF, Ghosh S, Panaccione R, et al.Targeted Biopsies Identify Larger Proportions of Patients With Colonic Neoplasia Undergo- ing High-Definition Colonoscopy, Dye Chromoendoscopy, or Electronic Virtual Chromoendoscopy. Clin Gastroenterol Hepatol 2016; 14: 704-12.e4. [CrossRef] 404 Turk J Gastroenterol 2016; 27: 403-4 Gas